SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-038893
Filing Date
2020-08-10
Accepted
2020-08-10 16:00:38
Documents
63
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q clsd-10q_20200630.htm 10-Q 1351898
2 EX-10.1 clsd-ex101_237.htm EX-10.1 43730
3 EX-10.2 clsd-ex102_238.htm EX-10.2 104870
4 EX-31.1 clsd-ex311_9.htm EX-31.1 16727
5 EX-31.2 clsd-ex312_7.htm EX-31.2 16497
6 EX-32.1 clsd-ex321_8.htm EX-32.1 9045
7 GRAPHIC gx0owp5elyjo000002.jpg GRAPHIC 30799
8 GRAPHIC gx0owp5elyjo000001.jpg GRAPHIC 21176
  Complete submission text file 0001564590-20-038893.txt   5019523

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT clsd-20200630.xml EX-101.INS 932413
10 XBRL TAXONOMY EXTENSION SCHEMA clsd-20200630.xsd EX-101.SCH 41068
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE clsd-20200630_cal.xml EX-101.CAL 36240
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE clsd-20200630_def.xml EX-101.DEF 124700
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE clsd-20200630_lab.xml EX-101.LAB 327225
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clsd-20200630_pre.xml EX-101.PRE 242266
Mailing Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA 2Q 30005
Business Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA 2Q 30005 678-270-3631
Clearside Biomedical, Inc. (Filer) CIK: 0001539029 (see all company filings)

IRS No.: 452437375 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37783 | Film No.: 201089219
SIC: 2834 Pharmaceutical Preparations